Suppr超能文献

新型I(Kur)通道阻滞剂S9947和S20951与I(Kr)阻滞剂多非利特、阿齐利特、d,l-索他洛尔和伊布利特相比,对猪左、右心房的电生理和抗心律失常作用。

Electrophysiological and antiarrhythmic effects of the novel I(Kur) channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the I(Kr) blockers dofetilide, azimilide, d,l-sotalol and ibutilide.

作者信息

Knobloch Karsten, Brendel Joachim, Peukert Stefan, Rosenstein Björn, Busch Andreas E, Wirth Klaus J

机构信息

DG Cardiovascular Diseases, Aventis Parma, Industriepark Höchst, Frankfurt am Main, Germany.

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 2002 Nov;366(5):482-7. doi: 10.1007/s00210-002-0599-x. Epub 2002 Sep 5.

Abstract

Inhibition of the cardiac Kv1.5 channel, the molecular base for the human cardiac ultrarapid delayed rectifier potassium current (I(Kur)), is considered a new promising atrial selective antiarrhythmic concept since this channel is presumed to contribute to atrial but not ventricular repolarization in the human heart. In a previous study in pigs we found clear baseline differences in refractoriness between left and right atrium with shorter effective refractory periods (ERPs) of the left atrium associated with a high left atrial vulnerability for tachyarrhythmias. In this newly established model we compared atrial and ventricular effects of two novel I(Kur) blockers, S9947 and S20951, with the I(Kr) blockers dofetilide, azimilide, ibutilide and d,l-sotalol. In pentobarbital anesthetized pigs (n=45) we determined ERPs in the free walls of both atria with the S1-S2-stimulus method at three basic cycle lengths (BCL 240/300/400 ms) and QTc-intervals. The incidence of atrial tachyarrhythmias triggered by the S2-extrastimulus of the left atrium was evaluated (referred to as left atrial vulnerability). In contrast to I(Kr) blockade, I(Kur) blockade had no effect on the QT-interval, but prolonged the atrial ERP. The I(Kur) blockers were significantly stronger on left atrial ERP, I(Kr) blockers on right atrial ERP (P<0.05 for all compounds tested). At 240 ms BCL the I(Kur) blocker S20951, 3 mg/kg, prolonged left vs. right atrial ERP by 28+/-5 ms vs. 12+/-3 ms and S9947, 3 mg/kg, by 45+/-7 ms vs. 19+/-6 ms. By contrast the effect of dofetilide, 10 microg/kg, was stronger on the right than left atrium (47+/-6 ms vs. 25+/-2 ms), a profile also found with azimilide (5 mg/kg, 43+/-3 ms vs. 17+/-3 ms), ibutilide (15 microg/kg, 70+/-10 ms vs. 29+/-4 ms) and d,l-sotalol (1.5 mg/kg, 57+/-6 ms vs. 36+/-4 ms). The I(Kur) blockers, S20951and S9947, significantly decreased left atrial vulnerability (-82% and -100%, respectively, P<0.01) in contrast to the selective I(Kr) blocker dofetilide (-14%; n.s.). In conclusion, I(Kur) and I(Kr) blockers showed substantial differences in their atrial and ventricular actions in pigs. I(Kr) blockers were stronger on right atrial ERP, I(Kur) blockers on left atrial ERP, suggesting interatrial differences in the expression of potassium channels. In contrast to selective I(Kr) blockade, I(Kur) blockade inhibited left atrial vulnerability and had no effect on the QT-interval. Thus, blockade of I(Kur) seems to be a promising atrial selective antiarrhythmic concept.

摘要

心脏Kv1.5通道是人类心脏超快速延迟整流钾电流(I(Kur))的分子基础,对其抑制作用被认为是一种新的、有前景的心房选择性抗心律失常理念,因为该通道被推测在人类心脏中仅参与心房而非心室的复极化过程。在之前一项针对猪的研究中,我们发现左、右心房在不应期方面存在明显的基线差异,左心房的有效不应期(ERP)较短,其发生快速性心律失常的易损性较高。在这个新建立的模型中,我们比较了两种新型I(Kur)阻滞剂S9947和S20951与I(Kr)阻滞剂多非利特、阿齐利特、伊布利特和消旋索他洛尔对心房和心室的作用。在戊巴比妥麻醉的猪(n = 45)中,我们采用S1 - S2刺激法在三个基础周期长度(BCL 240/300/400 ms)下测定了两心房游离壁的ERP以及QT间期。评估了由左心房S2额外刺激引发的房性快速性心律失常的发生率(称为左心房易损性)。与I(Kr)阻滞不同,I(Kur)阻滞对QT间期无影响,但可延长心房ERP。I(Kur)阻滞剂对左心房ERP的作用显著更强,I(Kr)阻滞剂对右心房ERP的作用更强(所有测试化合物的P均<0.05)。在240 ms BCL时,I(Kur)阻滞剂S20951(3 mg/kg)使左心房ERP较右心房ERP延长28±5 ms 对 12±3 ms,S9947(3 mg/kg)延长45±7 ms 对 19±6 ms。相比之下,多非利特(10 μg/kg)对右心房的作用比对左心房更强(47±6 ms 对 25±2 ms),阿齐利特(5 mg/kg)也有类似情况(43±3 ms 对 17±3 ms),伊布利特(15 μg/kg)(70±10 ms 对 29±4 ms)和消旋索他洛尔(1.5 mg/kg)(57±...

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验